Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:44 am Sale | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | Deep Track Capital, LP | 0 0.000% | -3,362,000 (Position Closed) | Filing History |
| 2023-02-13 6:17 pm Purchase | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | BIOTECHNOLOGY VALUE FUND LP | 3,800,983 5.700% | 253,900 (+7.16%) | Filing History |
| 2023-02-13 1:07 pm Purchase | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | SUVRETTA CAPITAL MANAGEMENT, LLC | 6,376,815 9.300% | 2,804,396 (+78.50%) | Filing History |
| 2023-02-10 1:48 pm Purchase | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | EcoR1 Capital, LLC | 6,638,371 9.900% | 2,094,924 (+46.11%) | Filing History |
| 2023-02-10 10:05 am Sale | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | Flynn James E | 2,383,000 3.560% | -1,130,756 (-32.18%) | Filing History |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | Kura Oncology, Inc. KURA | The Vanguard Group | 3,405,169 5.090% | 3,405,169 (New Position) | Filing History |
| 2023-02-03 12:15 pm Purchase | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | STATE STREET CORP STT | 4,446,427 6.650% | 1,068,284 (+31.62%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | BlackRock Inc. BLK | 5,162,836 7.600% | 67,810 (+1.33%) | Filing History |
| 2022-12-05 4:45 pm Purchase | 2022-11-23 | 13G | Kura Oncology, Inc. KURA | BIOTECHNOLOGY VALUE FUND LP | 3,547,083 5.300% | 2,301,171 (+184.70%) | Filing History |
| 2022-03-10 09:48 am Sale | 2022-03-09 | 13G | Kura Oncology, Inc. KURA | FMR LLC | 241,463 0.362% | -5,340,737 (-95.67%) | Filing History |
| 2022-02-11 4:55 pm Purchase | 2021-12-31 | 13G | Kura Oncology, Inc. KURA | SUVRETTA CAPITAL MANAGEMENT, LLC | 3,572,419 5.400% | 69,000 (+1.97%) | Filing History |
| 2022-02-11 2:03 pm Purchase | 2021-12-31 | 13G | Kura Oncology, Inc. KURA | STATE STREET CORP STT | 3,378,143 5.080% | 3,378,143 (New Position) | Filing History |
| 2022-02-03 9:43 pm Purchase | 2022-01-28 | 13G | Kura Oncology, Inc. KURA | Deep Track Capital, LP | 3,362,000 5.050% | 3,362,000 (New Position) | Filing History |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Kura Oncology, Inc. KURA | BlackRock Inc. BLK | 5,095,026 7.700% | 163,070 (+3.31%) | Filing History |
| 2022-01-31 4:39 pm Purchase | 2022-01-21 | 13G | Kura Oncology, Inc. KURA | EcoR1 Capital, LLC | 4,543,447 6.800% | 2,770,410 (+156.25%) | Filing History |
| 2022-01-10 1:26 pm Sale | 2022-01-07 | 13G | Kura Oncology, Inc. KURA | FMR LLC | 5,582,200 8.387% | -3,533,840 (-38.77%) | Filing History |
| 2021-12-09 4:31 pm Purchase | 2021-11-29 | 13G | Kura Oncology, Inc. KURA | SUVRETTA CAPITAL MANAGEMENT, LLC | 3,503,419 5.300% | 3,503,419 (New Position) | Filing History |
| 2021-12-03 3:07 pm Purchase | 2021-11-29 | 13G | Kura Oncology, Inc. KURA | Flynn James E | 3,513,756 5.280% | 3,513,756 (New Position) | Filing History |
| 2021-02-16 12:00 pm Sale | 2020-12-31 | 13G | Kura Oncology, Inc. KURA | EcoR1 Capital, LLC | 1,773,037 2.700% | -2,468,916 (-58.20%) | Filing History |
| 2021-02-12 08:09 am Purchase | 2020-12-31 | 13G | Kura Oncology, Inc. KURA | Avoro Capital Advisors LLC | 4,000,000 6.200% | 4,000,000 (New Position) | Filing History |